• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CSF VALVE; SHUNT, CENTRAL NERVOUS SYSTEM & COMPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CSF VALVE; SHUNT, CENTRAL NERVOUS SYSTEM & COMPS Back to Search Results
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem No Information (3190)
Event Date 07/31/2006
Event Type  Injury  
Manufacturer Narrative
It has been communicated that the device is not available for evaluation.Without the device it is not possible for codman to conduct a proper investigation.Since a lot number has been provided a review of the manufacturing records will be reviewed.We anticipate that the evaluation will reveal that the device conformed to specifications prior to release.If anything otherwise is found then a follow up report will be filed.If at some point the device does become available, this complaint will be re-opened, evaluated and a follow up report will be filed.Trends will be monitored for this and similar complaints.At the present time this complaint is considered closed.
 
Event Description
In the literature search ¿case report: programmable shunt-related suicide attempt¿ published acta neurochir (wien) (2006) 148: 1307¿1310, doi 10.1007/s00701-006-0850-1, it was reported that a (b)(6) male attempted suicide by alcohol, medications and self-adjustment of his programmable csf valve.Per the article: ¿the treatment of hydrocephalus has benefited recently from the use of programmable shunt valves.These devices can be adjusted using magnets to regulate how much spinal fluid is drained.However, it is unclear to what extent other environmental magnetic sources can affect programmable valves.We present the case of a man who attempted suicide by successfully turning his adjustable valve to a near-maximal setting using a hand-held electromagnet, and discuss other reported cases in order to better understand the effects of environmental magnets on programmable shunt valves¿.A head ct was performed emergently and showed marked ventriculomegaly when compared to his previous study.In addition, a plain film was obtained to evaluate his valve setting, which was found to be at a near-maximal setting of 190mm of water.The patient¿s shunt was tapped, his valve was turned down to 120mm, and he was admitted for observation.Because his shunt appeared to be functioning properly, we spared him another surgery to interrogate and revise the shunt or convert it to a third ventriculostomy.By the next morning, his mental status had improved and, after psychiatric evaluation, he was discharged to his family¿s care.¿ at the time of complaint entry no device specific information, i.E.Catalogue/lot number, is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CSF VALVE
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM & COMPS
Manufacturer Contact
james kenney
325 paramount drive
raynham, MA 02767
5088282726
MDR Report Key6041496
MDR Text Key57872157
Report Number1226348-2016-10735
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Other
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/19/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received09/28/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age54 YR
-
-